CLINICAL_TRIALS
trial_result
· 2015-10-05
Clinical Trial Update: Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects [Phase 2]
Summary
Phase 2 trial evaluating PL2200 versus aspirin for upper GI ulceration risk in at-risk subjects has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PLx Pharma | Conditions: Gastroduodenal Ulceration | Phase 2 | Status: COMPLETED | Results posted: 2015-10-05